Helen Mogun, MS

  • 2Articles
  • 21.9KReads1
  • 2019–2023Active
  • 21Collaborators
  • 18Citations2

About

Helen Mogun, MS, is affiliated with the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital and Harvard Medical School. Her publications from 2019 to 2023 focus on mood disorders and women's health, specifically examining the effects of medications such as atomoxetine and anticonvulsant mood stabilizers during pregnancy. She has collaborated frequently with Brian T. Bateman, Krista F. Huybrechts, Anders Engeland, Anna-Maria Lahesmaa-Korpinen, and Elisabetta Patorno.

Publications

JCP
Atomoxetine and Prevalence of Major Congenital Malformations
Original Research

Atomoxetine and Prevalence of Major Congenital Malformations

image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ January 16, 2023

Little is known about the safety of atomoxetine, a non-stimulant treatment for attention-deficit/hyperactivity disorder. This study assessed the prevalence of major congenital malformations after first-trimester exposure to atomoxetine.
, , , et al
JCP
Original Research

Mood Stabilizers and Placenta-Mediated Complications

June 18, 2019

Women who take mood stabilizers have a greater risk of placenta-mediated pregnancy complications. But are the mood stabilizers themselves responsible for this higher risk? This study explores that question.
, , , et al

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Insightful. Evidence-based. Human-centered.

Listen Now
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe